Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2021 - 06 - 01 source : Www.biospace.com save search
Grifols introduces HyperHEP B® (hepatitis B immune globulin [human]), a new formulation to treat patients exposed to hepatitis B
Published: 2021-06-01 (Crawled : 21:00) - biospace.com/
GRFS | News | $6.29 -3.82% -3.97% 1.2M
|
Health Technology
|
| O: 1.77%
H: 1.8%
C: -1.63%
hepatitis
MEDISCA Strategic Partnership Stabilizes Industry Supply of Thyroid API
Published: 2021-06-01 (Crawled : 19:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.93%
H: 0.09%
C: -0.87%
partnership
Janssen Highlights Commitment to Advancing Transformative Innovations in Oncology with Scientific Updates from Deep, Diverse Pipeline and Portfolio at ASCO and EHA Virtual Scientific Programs
Published: 2021-06-01 (Crawled : 19:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.53%
H: 0.03%
C: -2.72%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: -0.2%
H: 0.1%
C: -0.81%
Sanofi Halts Kidney Disease Program Studying Venglustat Drug
Published: 2021-06-01 (Crawled : 17:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.93%
H: 0.09%
C: -0.87%
disease drug kidney program
TRACON Pharmaceuticals Announces Results of Independent Data Monitoring Committee Review of Safety Data from ENVASARC Pivotal TrialTrial to Continue as Planned
Published: 2021-06-01 (Crawled : 16:00) - biospace.com/
TCON | $1.97 -6.64% -7.11% 240K
|
Health Technology
|
| O: 1.16%
H: 3.2%
C: -1.31%
results trial
RNA Disease Diagnostics Further Strengthens Executive Leadership with Appointment of John W. Erickson, Jr. as President
Published: 2021-06-01 (Crawled : 16:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.53%
H: 0.03%
C: -2.72%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -5.57%
H: 1.04%
C: -3.96%
disease diagnostics diagnostic
Immutep Enters Into A New Collaboration With Merck KGaA, Darmstadt, Germany For LAG-3 Therapy, Efti
Published: 2021-06-01 (Crawled : 16:00) - biospace.com/
IMMP | $2.25 2.27% 2.22% 90K
|
Health Technology
|
| O: 6.35%
H: 1.43%
C: -2.8%
therapy collaboration germany
Acuamark Diagnostics Welcomes Dr. Cedric Francois To Its Board of Directors
Published: 2021-06-01 (Crawled : 15:00) - biospace.com/
APLS G | $47.53 0.04% 0.04% 1.2M
|
Health Technology
|
| O: 0.21%
H: 4.43%
C: 2.84%
diagnostics diagnostic
Precision NanoSystems joins Danaher's Life Sciences Platform
Published: 2021-06-01 (Crawled : 15:00) - biospace.com/
DHR | $235.51 -0.36% 0.0% 2.3M
|
Health Technology
|
| O: -0.84%
H: 0.0%
C: -3.46%
life science platform
Medtronic Announces Scientific Data Presentations at the 14th International Conference on Advanced Technologies & Treatments for Diabetes
Published: 2021-06-01 (Crawled : 15:00) - biospace.com/
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
|
| O: 1.17%
H: 0.04%
C: -2.56%
presentation diabetes treatment conference
BeiGene Announces First Presentation of the Phase 3 ALPINE Trial Comparing BRUKINSA® (Zanubrutinib) to Ibrutinib in Chronic Lymphocytic Leukemia to Be Featured in Presidential Symposium at EHA2021
Published: 2021-06-01 (Crawled : 15:00) - biospace.com/
BGNE | $129.51 -1.86% -1.89% 300K
|
Health Technology
|
| O: 0.42%
H: 2.35%
C: 1.95%
presentation brukinsa leukemia phase 3 trial symposium
Amwell to Participate in the 42nd Annual Goldman Sachs Global Healthcare Conference
Published: 2021-06-01 (Crawled : 14:00) - biospace.com/
AMWL | $0.5466 5.54% -0.22% 2.1M
|
Technology Services
|
| O: 0.72%
H: 3.47%
C: 2.31%
conference
180 Life Sciences Corp. to Present at LD Micro Invitational XIManagement to Present Thursday June 10th
Published: 2021-06-01 (Crawled : 14:00) - biospace.com/
ATNF | $1.87 2.19% 2.14% 20K
|
|
| O: 3.28%
H: 7.71%
C: 5.44%
life science presentation
Janssen Announces U.S. FDA Breakthrough Therapy Designation Granted for Teclistamab for the Treatment of Relapsed or Refractory Multiple Myeloma
Published: 2021-06-01 (Crawled : 14:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.53%
H: 0.03%
C: -2.72%
treatment fda therapy breakthrough therapy grant designation
Hoth Therapeutics Plans Shareholder Presentation on HT-KIT Therapeutic's Preclinical Results for Rare Cancers
Published: 2021-06-01 (Crawled : 14:00) - biospace.com/
HOTH | $1.22 3.39% 3.28% 22K
|
Health Technology
|
| O: 0.69%
H: 5.48%
C: 4.79%
presentation results cancer preclinical therapeutics pre-clinical rare
Viracta Therapeutics Announces the Initiation of NAVAL-1, a Global Pivotal Trial for the Treatment of Relapsed/Refractory Epstein-Barr Virus-Positive Lymphoma
Published: 2021-06-01 (Crawled : 14:00) - biospace.com/
VIRX | $0.88 -3.19% -3.3% 53K
|
Manufacturing
|
| O: -3.66%
H: 6.3%
C: -0.9%
treatment positive trial
Ajax Therapeutics Raises $40 Million Financing To Develop Novel Small Molecules Targeting Cytokine Signaling Pathways for Hematologic Malignancies
Published: 2021-06-01 (Crawled : 13:15) - biospace.com/
SDGR | $24.31 -0.12% -0.12% 600K
|
Technology Services
|
| O: 0.87%
H: 1.4%
C: 1.03%
Hanger to Present at the Jefferies Virtual Healthcare Conference
Published: 2021-06-01 (Crawled : 13:00) - biospace.com/
HNGR | $18.72 0.0%
|
Health Services
|
| O: 1.2%
H: 1.11%
C: -0.73%
conference presentation
Establishment Labs Announces Appointments of Heather Brennan as Head of U.S. Commercial Operations and Neeta Toprani as General Counsel & Corporate Secretary
Published: 2021-06-01 (Crawled : 13:00) - biospace.com/
ESTA | $47.425 -9.79% -10.85% 430K
|
Health Technology
|
| O: 1.85%
H: 0.15%
C: -2.3%
commercialization
Lengo Therapeutics Appoints Diana Hausman as Chief Medical Officer
Published: 2021-06-01 (Crawled : 13:00) - biospace.com/
ZYME | $8.85 2.08% 2.03% 550K
|
Health Technology
|
| O: 1.44%
H: 2.12%
C: 1.23%
therapeutics
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.